Response to Talks et al

C. K. Chan; P. Abraham; D. Sarraf

doi:10.1038/eye.2012.209

Response to Talks et al

C. K. Chan, P. Abraham, D. Sarraf

Ophthalmology

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1600-1601
Number of pages	2
Journal	Eye
Volume	26
Issue number	12
DOIs	https://doi.org/10.1038/eye.2012.209
State	Published - Dec 2012

ASJC Scopus Subject Areas

Ophthalmology
Sensory Systems

Access to Document

10.1038/eye.2012.209License: Unspecified

OpenUrl availability

Full text

Cite this

@article{eb6a220842c54995a333e4104cdbff4c,

title = "Response to Talks et al",

author = "Chan, {C. K.} and P. Abraham and D. Sarraf",

note = "Funding Information: This study was supported by Genentech Inc. (CKC, PA, DS), Owen Locke Foundation (CKC), and Karl Kirchgessner Foundation (DS). This report constitutes the clinical application of a non-FDA approved dosage of an FDA approved medication.",

year = "2012",

month = dec,

doi = "10.1038/eye.2012.209",

language = "English",

volume = "26",

pages = "1600--1601",

journal = "Eye",

issn = "0950-222X",

number = "12",

}

TY - JOUR

T1 - Response to Talks et al

AU - Chan, C. K.

AU - Abraham, P.

AU - Sarraf, D.

N1 - Funding Information: This study was supported by Genentech Inc. (CKC, PA, DS), Owen Locke Foundation (CKC), and Karl Kirchgessner Foundation (DS). This report constitutes the clinical application of a non-FDA approved dosage of an FDA approved medication.

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84871047003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871047003&partnerID=8YFLogxK

U2 - 10.1038/eye.2012.209

DO - 10.1038/eye.2012.209

M3 - Letter

SN - 0950-222X

VL - 26

SP - 1600

EP - 1601

JO - Eye

JF - Eye

IS - 12

ER -

Response to Talks et al

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this